Paula Kaplan‐Lefko

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade”.

Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006930

N/A

0.793DataRank · unranked

18 citations

Arun S. Singh, Cole W. Peters, Begoña Comı́n-Anduix, Beata Berent-Maoz, Mignonette H. Macabali +7 more

Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny

Nature Communications(2025)10.1038/s41467-025-60816-z

N/A

0.281DataRank · unranked

4 citations

Nataly Naser Al Deen, Cole W. Peters, Begoña Comı́n-Anduix, Egmidio Medina, Cristina Puig-Saus +28 more

Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0577

N/A

0DataRank · unranked

4 citations

Cole W. Peters, Crystal Quiros, Conner K. Kidd, Moe Kawakami, Alexandra M. Klomhaus +8 more